139 related articles for article (PubMed ID: 194447)
1. Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
Olgaard K; Hagen C; Madsen S; Hummer L
Acta Endocrinol (Copenh); 1977 Jul; 85(3):587-94. PubMed ID: 194447
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone response to ACTH stimulation in anephric and non-nephrectomized patients on regular hemodialysis.
Olgaard K; Madsen S
Acta Med Scand; 1977 Jan; 201(1-2):77-82. PubMed ID: 189578
[TBL] [Abstract][Full Text] [Related]
3. Plasma aldosterone during extracellular fluid volume expansion in patients on regular haemodialysis.
Olgaard K; Madsen S; Ladefoged J; Regeur L
Eur J Clin Invest; 1977 Feb; 7(1):61-6. PubMed ID: 402278
[TBL] [Abstract][Full Text] [Related]
4. The adrenocortical response to angiotensin II infusion in anephric and non-nephrectomized patients on regular hemodialysis.
Olgaard K; Madsen S; Hammer M
Acta Med Scand; 1977; 202(3):213-9. PubMed ID: 199049
[TBL] [Abstract][Full Text] [Related]
5. Plasma aldosterone in anephric and non-nephrectomized dialysis patients in relation to changes in plasma potassium without change in total potassium balance.
Olgaard K
Acta Med Scand; 1975 Sep; 198(3):213-8. PubMed ID: 1180127
[TBL] [Abstract][Full Text] [Related]
6. Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man.
degli Uberti EC; Fabbri BL; Margutti AR; Fersini CM; Pansini R
Horm Res; 1979; 10(2-3):64-78. PubMed ID: 220171
[TBL] [Abstract][Full Text] [Related]
7. Calcium-dependent aldosterone secretion in anephric and nonnephrectomized patients on regular hemodialysis.
Olgaard K; Madsen S; Hammer M; Ladefoged J
J Clin Endocrinol Metab; 1978 May; 46(5):740-6. PubMed ID: 233632
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the plasma-aldosterone response to frusemide by bromocriptine.
Edwards CR; Miall PA; Hanker JP; Thorner MO; Al-Dujaili EA; Besser GM
Lancet; 1975 Nov; 2(7941):903-5. PubMed ID: 53377
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasma aldosterone in anephric and non-nephrectomized patients during hemodialysis treatment.
Olgaard K; Madsen S
Acta Med Scand; 1977; 201(5):457-62. PubMed ID: 899867
[TBL] [Abstract][Full Text] [Related]
10. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone and prolactin.
Olgaard K; Hagen C; Madsen S; Hummer L
Lancet; 1976 Oct; 2(7992):959. PubMed ID: 62181
[No Abstract] [Full Text] [Related]
12. Bromocriptine-induced modulation of plasma aldosterone response to acute stimulations.
Birkhäuser M; Riondel A; Vallotton MB
Acta Endocrinol (Copenh); 1979 Jun; 91(2):294-302. PubMed ID: 223355
[TBL] [Abstract][Full Text] [Related]
13. Hormonal responses to acute volume changes in anephric subjects.
Cooke CR; Gann DS; Whelton PK; Hsu TH; Bledsoe T; Moore MA; Walker WG
Kidney Int; 1983 Jan; 23(1):71-8. PubMed ID: 6300506
[TBL] [Abstract][Full Text] [Related]
14. Prolactinemia during hemodialysis: lack of correlation with sodium, potassium and renin-aldosterone system.
Sciarra F; Sparano F; Giaquinto G; Odoardi A; Mercuri MA; Concolino G
Horm Res; 1977; 8(3):129-38. PubMed ID: 903075
[TBL] [Abstract][Full Text] [Related]
15. Circadian rhythm of plasma aldosterone and time dependent alterations of aldosterone regulators.
Takeda R; Miyamori I; Ikeda M; Koshida H; Takeda Y; Yasuhara S; Morise T; Takimoto H
J Steroid Biochem; 1984 Jan; 20(1):321-3. PubMed ID: 6323866
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
[TBL] [Abstract][Full Text] [Related]
17. Control of plasma aldosterone in supine anephric man.
Vetter W; Záruba K; Armbruster H; Beckerhoff R; Reck G; Sigenthaler W
Clin Endocrinol (Oxf); 1974 Oct; 3(4):411-9. PubMed ID: 4372001
[No Abstract] [Full Text] [Related]
18. Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease.
Weidmann P; Maxwell MH; Rowe P; Winer R; Massry SG
Nephron; 1975; 15(1):35-49. PubMed ID: 165438
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine does not inhibit the aldosterone response to sodium depletion.
Carey RM; Van Loon GR
J Clin Endocrinol Metab; 1982 Jul; 55(1):162-5. PubMed ID: 7042738
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects.
Cooke CR; Whelton PK; Moore MA; Caputo RA; Bledsoe T; Walker WG
Kidney Int; 1979 Jun; 15(6):669-75. PubMed ID: 572442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
